| 摘要 |
PROBLEM TO BE SOLVED: To provide a new means for diagnosing heterotopic endometriosis. SOLUTION: This means for diagnosing the heterotopic endometriosis in vitro is characterized by measuring the amount of at least one genetic product selected from the group consisting of fibronectin, insulin-like proliferation factor- bound protein-2, membrane-penetrating receptor PTK7, platelet-originated proliferation factor receptor alpha, collagen XVIII type alpha 1, subtilisin-like protein (PACE 4), laminin M chain (merosin), elastin, IV type collagen alpha 2, p27 interferon alpha-derived gene, reticulocalbin, aldehyde dehydrogenase 6, gravin, nidogen, and phospholipase C epsilon in a patient sample, comparing the measured amount with the amount of the genetic product in a control sample, and allowing to suggest the presence of the heterotopic endometriosis by showing that the amount of the genetic product in the patient sample is less than the amount of the genetic product in the control sample. |
